Answers are grounded in this paper and cite their sources.
HIV-specific antibodies (Abs) may contribute to the elimination of HIV reservoirs by binding to reactivated cells and targeting them for antibody-dependent cell-mediated cytotoxicity (ADCC) (1, 2). Broadly neutralizing antibodies (bNAbs) may be particularly efficacious, by mediating virus neutralization alongside ADCC for multiple HIV strains (in the context of untreated simian-human immunodeficiency virus [SHIV] infection, neutralization rather than ADCC appears to dominate the antiviral effect of bNAb infusion [3, 4]). Few studies have assessed the activities of bNAbs against reservoir-derived viruses. The relationships between neutralizing activity, ADCC function, and binding to reservoir virus in infected primary CD4+ T cells have not been comprehensively studied. In a study previously published by Ren et al. (5), we tested a panel of 14 bNAbs against 36 reservoir-derived viral isolates, demonstrating that susceptibility to neutralization by broadly neutralizing antibodies generally correlated with infected-cell binding for a panel of clade B HIV reactivated from latent reservoirs.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: